Meeting physical activity guidelines is associated with reduced risk for cardiovascular disease in black South African women; a 5.5-year follow-up study
Low levels of physical activity (PA) have been associated with increased risk for cardiovascular disease (CVD) and type 2 diabetes (T2D), but few studies have examined whether meeting international PA guidelines is associated with reduced risk in a black South African (SA) population. The aims of this study were to compare body composition and cardio-metabolic risk factors for CVD and T2D between active and inactive groups (part 1, cross-sectional analysis) and, to determine whether PA level predicts changes in body composition and cardio-metabolic risk factors for CVD and T2D at follow-up after 5.5-years (part 2, longitudinal analysis).
Methods
Part 1 included a sample of 240 apparently healthy black SA women (26 ± 7 years) who underwent the following measurements at baseline: PA (Global Physical Activity Questionnaire (GPAQ)), body composition and regional fat distribution (dual-energy x-ray absorptiometry and computerised tomography), blood pressure, fasting glucose, insulin and lipid concentrations. For part 2, a sub-sample of women (n = 57) underwent the same measurements after a 5.5-year period.
Results
At baseline, 61% of women were classified as meeting the guidelines for moderate- to vigorous-intensity physical activity (MVPA) according to GPAQ. Women who were active had significantly lower body weight (p < 0.001), body fat (BMI, fat mass, % body fat, waist circumference, central and appendicular fat mass, all p < 0.001), and measures of insulin resistance (fasting serum insulin and HOMA-IR, both p = 0.01), and higher high-density lipoprotein cholesterol (p = 0.041), compared to the inactive group. At follow-up, all body fat measures increased significantly in both groups and diastolic blood pressure decreased significantly in those who were active at baseline, but did not change in those who were inactive.
Conclusions
Meeting PA guidelines was associated with decreased risk for CVD and T2D in black SA women, but did not prevent the increase in body fat over time. Interventions promoting physical activity to specifically address obesity in this high-risk group are recommended.
Keywords
Meeting international physical activity guidelinesbody compositioncardio-metabolic outcomes
Background
Data from longitudinal cohort studies conducted in the USA have shown that when physical activity (PA) is promoted, it has a positive impact by reducing the risk of cardiovascular disease (CVD) [1, 2]. Subsequently, the World Health Organization (WHO) has implemented several public health recommendations to increase PA, in an attempt to reduce disease risk. Accordingly, those who meet the global recommendations of PA for health are referred to as ‘sufficiently active’ and, engage in at least 150 minutes of moderate-intensity activity per week; or 75 minutes of vigorous-intensity activity per week; or an equivalent combination of moderate- to vigorous-intensity physical activity (MVPA) [3].
To date, a wide range of methods has been used to measure PA in adults. These include self-report methods such as questionnaires, activity logs and diaries [4]. The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS) was initiated in 2000, and uses the Global Physical Activity Questionnaire (GPAQ) to collect PA data in both high-income countries (HICs) [5] and low- and middle-income countries (LMICs) [6] defined by the World Bank. Benefits of its use include domain-specific PA data collected during work, transport and leisure time. Results from the most recent South African Demographic Health Survey (SADHS) [7] show that only 14% of women were sufficiently active, the majority of PA was achieved during leisure-time (53.9%), with a 13.1% difference shown between black African urban (49.8%) and rural (62.9%) groups. The contribution of work- and transport-related PA to overall PA (18.4% and 27.6%, respectively) were lower than leisure-time PA, with smaller differences between black African urban and rural groups (5.1% and 8.1%, respectively). In addition, women with no formal education were the most inactive (68%). In contrast, smaller studies in SA have shown black rural women accumulate more activity than black women living in urban settings [8–10]. These results therefore suggest that black urban SA women are a particularly vulnerable group for low levels of habitual PA.
Although previous SA studies have examined the association between PA, body composition and body fat distribution measures [11, 12], most have used body mass index (BMI) and waist circumference (WC). To our knowledge there are no studies that have used more precise body composition and body fat distribution measures such as dual-energy x-ray absorptiometry (DXA) and computerised tomography (CT). This is important as PA has been shown to differentially alter body composition within the adipose tissue depots, with some studies showing greater relative changes in visceral adipose tissue (VAT) compared to subcutaneous adipose tissue (SAT) in response to exercise interventions [13, 14]. Black SA women have significantly less VAT and more abdominal SAT than white women, despite being more insulin resistant [15–17], however no studies have examined the association between PA and these fat depots in this population.
Cross-sectional data from studies in Sub-Saharan Africa (SSA) [10, 18] support evidence from larger international prospective female cohort studies [19, 20] showing an inverse association between MVPA and cardio-metabolic disease risk. Results from small-scale SA and Cameroonian adult women studies showed similar inverse associations between PA energy expenditure (PAEE) and fasting plasma glucose levels [10, 21], and 2-hour plasma glucose levels [18]. However, it remains unknown if being physically active (meeting global PA recommendations for health) [3] will reduce the risk and onset of CVD and type 2 diabetes (T2D) over time, particularly among women living in LMICs such as SA. Therefore, the aims of this study were i) to compare body composition measures and cardio-metabolic risk factors for CVD and T2D between active and inactive groups and ii) to determine whether baseline PA level predicts changes in body composition and cardio-metabolic risk factors for CVD and T2D at the end of a 5.5-year follow-up period.
Methods
Participants
Participants included 240 apparently healthy premenopausal black SA women who were tested in 2005/6, the details of which have been published previously [22, 23]. The women were recruited from church groups, community centers, and universities and through the local press, and were included in the study if they were i) 18–45 years old; ii) had no known diseases and were not taking medications for T2D, hypertension, HIV/AIDS, or any other cardio-metabolic diseases; iii) were not pregnant, lactating or postmenopausal (self-reported); and iv) of SA ancestry (self-reported). For the purposes of this study, 9 women were excluded from the original cohort based on invalid PA data in 2005/6 as instructed by the GPAQ Analysis Guide [24].
The original cohort (n = 231) of women were contacted and invited to participate in the follow-up study in 2010/11. Of the original sample 126 were non-contactable, 38 women refused to participate in the present study, 8 women disclosed they were HIV-positive and/or taking anti-retroviral medication, 1 woman was deceased, and another woman had recently given birth and was lactating. Voluntary HIV screening was performed and participants were further excluded on the basis of a confirmed positive test (Sanitests Home Test Kits, SA). Those who declined HIV screening were not excluded from the sample. Only 57 women of the original baseline sample underwent follow-up testing and were included in the follow-up subsample analysis. Testing procedures were identical to those at baseline. The same Xhosa-speaking fieldworker involved in the original baseline study assisted with the participant recruitment and testing at follow-up. Ethical approval for this research study (Ref. No. 101/2004) was obtained from the Research and Ethics Committee of the Faculty of Health Sciences, from the University of Cape Town.
Socio-economic status and behaviour/lifestyle factors
At baseline and follow-up, a socio-demographic questionnaire was administered that included measures of socio-economic status (SES), family history of CVD and T2D (first degree relatives), and behavioural/lifestyle factors. Four indicators of SES were used: education (completion of secondary school), employment, housing density and asset index. An asset index score was based on 14 items reflecting individual and household wealth and resources. This included electricity in the home, ownership of a television, radio, motor vehicle, fridge, stove/oven, washing machine, telephone, video machine, microwave, computer, cellular telephone and paid television channels. Participants were categorised as employed or unemployed. Students were categorised as unemployed. Housing density was defined as the number of persons in the household divided by the number of rooms. Behavioural/lifestyle factors included current smoking status (categorised as smoker or non-smoker), alcohol consumption based on average weekly intake of alcohol (categorised as women who consumed ≥1 drink per day as consumers of alcohol), and hormonal contraceptive use (oral or injectable vs. none).
Body composition assessment
Weight and height, in lightweight clothing without shoes, were measured using a standard scale and stadiometer, respectively (Detecto, Model UWE BW-150, Cardinal Scale Manufacturers, Webb City, Missouri, USA). WC at the level of umbilicus, and hip circumference at the greatest protuberance of the buttocks were measured.
Whole body composition, including fat mass (FM) and fat-free soft tissue mass (FFSTM), was measured by dual energy x-ray absorptiometry (DXA, Discovery-W®, software version 12.7.3.7; Hologic, Bedford, MA) according to standard procedures. In vivo precision (CV) was 0.7% and 1.67% for FFSTM and FM, respectively. Regional body fat distribution was characterised as central fat mass (CFM) and appendicular fat mass (AFM), as previously described [25]. Those participants whose body proportions exceeded the DXA scanning area were analysed using the arm-replacement method, which replaces the data obtained for the left arm with the data obtained for the right arm [26]. A single-slice computerised tomography (CT) (Toshiba X-press Helical Scanner®; Toshiba Medical Systems, Tokyo, Japan) scan was taken at the level of the L4-L5 lumbar vertebrae to determine VAT and SAT areas [27].
Cardio-metabolic risk factors for CVD and T2D
Cardio-metabolic measurements including resting blood pressure (BP), fasting serum lipid levels, fasting plasma glucose and serum insulin concentrations were measured at baseline and follow up. After at least 5 minutes of seated rest, BP was measured three times at 1-minute intervals using an appropriate-sized cuff and an automated BP monitor (Omron® 711; Omron Health Care, Hamburg, Germany). An average of the last two readings was used for analyses.
Serum total cholesterol (TC) (intra-assay %CV: 0.4%), triglyceride (TG) (intra-assay %CV: 0.6%), and high-density lipoprotein cholesterol (HDL-C) (intra-assay %CV: 0.55%) concentrations were measured on the Roche Modular Auto Analyzer (Roche/Hitachi Cobas C System from Roche Diagnostics GmbH, D-68298, Mannheim) using enzymatic colorimetric assays. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald equation [28]. Fasting plasma glucose levels at baseline and follow-up were measured using the glucose oxidase method [(Baseline: Glucose Analyzer 2, Beckman Instruments, Fullerton, CA, USA with intra-assay CV: 0.67%)] [Follow-up: YSI 2300 STAT PLUS, YSI Life Sciences, Yellow Springs, OH with intra-assay CV: 1.17% and inter-assay CV: 2.29%)]. An inter-method comparison was performed and yielded an inter-assay CV of 1.53%. Serum insulin levels were measured by a Micro-particle Enzyme Immunoassay (MEIA) (AxSym Insulin Kit, Abbot, IL, USA) [Baseline: intra-assay CV: 2.3% and inter-assay CV: 3.2%)] [Follow-up: intra-assay CV: 3.28% and inter-assay CV: 5.45%)]. The homeostasis model of insulin resistance (HOMA-IR) was calculated from the fasting insulin and glucose concentrations at both baseline and follow-up [29].
Physical activity
Physical activity data was collected using the GPAQ [24, 30], which has been shown to be similarly reliable and valid for use in SA [7], and with accelerometry as an objective PA measure in a LMIC context [31]. An introductory text explaining which activities to consider for each of the different domains, as well as the definitions of moderate-intensity and vigorous-intensity PA, was read out to each participant. Total PA time recorded in minutes per week (min/week) according to intensity bands (total moderate, total vigorous and MVPA) were calculated for each of the three domains (work, active commuting and leisure).
The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS) uses the GPAQ and GPAQ Analysis Guide criteria to categorise active and inactive groups [24]. The large baseline cohort (n = 231) was categorised into the two activity groups. Those who met the following criteria were defined as active: 30 minutes of moderate-intensity activity or walking per day, on at least 5 days in a typical week; or 20 minutes of vigorous-intensity activity per day on at least 3 days in a typical week; or 5 days of any combination of walking and moderate- or vigorous-intensity activities achieving a minimum of at least 600 MET-minutes per week. Those who did not meet these criteria were classified as inactive.
Statistical analysis
Data are presented as means ± standard deviations, or percentages (n). Chi-squared tests were used to examine differences between categorical data (behaviour/lifestyle factors) at baseline and follow-up. Non-normally distributed variables (PA, HDL-C, TG and serum insulin levels) were normalized by log transformation for parametric analyses.
Two-way analysis of covariance (ANCOVA) adjusting for differences in age was used to compare body composition and body fat distribution measures between active and inactive groups. Furthermore, an ANCOVA, adjusting for age, as well as age and weight, was used to compare cardio-metabolic outcomes measured between the two activity groups.
Changes in body composition, body fat distribution and cardio-metabolic outcome measurements over the 5.5-year follow-up period were assessed using repeated measures ANOVA, adjusting for age (for body composition outcomes), and age and weight (for cardio-metabolic outcomes), with Tukey post-hoc analyses. Statistical significance was based on a p < 0.05. All data were analysed using STATISTICA version 10 (StatSoft Inc. Tulsa, OK, USA).
Results
Physical activity
According to the GPAQ [24] Analysis Guide criteria (http://www.who.int/chp/steps/resources/GPAQ_Analysis_Guide.pdf), 61% of the women were classified as active. The individual and group PA data (min/week) for the active and inactive groups, broken down into the various intensity bands (total moderate, total vigorous and total moderate-vigorous) and domains (work-, transport- and leisure-time) according to the GPAQ criteria, are presented in Figure 1 and Table 1. By design, women classified as active by definition reported more min/week, in all PA domains. Notably, the majority of PA time recorded by both groups was reported for transport (domain) and performed at a moderate intensity (walking).
Figure 1
A diagrammatic comparison of weekly physical activity time between active and inactive groups(medians with inter-quartile ranges presented in Table1).
Table 1
Comparison of physical activity time measured using the GPAQ between active and inactive groups
Physical activity time
Active ( n = 141)
Inactive ( n = 90)
p values
Total vigorous (min/week)
0 (0–90)
0 (0–0)
<0.001
Total moderate (min/week)
540 (300–1080)
60 (0–140)
<0.001
Total MVPA (min/week)
610 (360–1200)
60 (0–180)
<0.001
Work
Total work (min/week)
0 (0–30)
0 (0–0)
<0.001
Transport
Total travel (min/week)
360 (160–840)
45 (0–140)
<0.001
Leisure
Total leisure (min/week)
0 (0–180)
0 (0–0)
<0.001
Values are medians with inter-quartile range in parenthesis. MVPA, moderate- to vigorous-intensity physical activity. PA time (work, transport and leisure) were normalized by log transformation for parametric analyses (ANOVA).
Baseline socio-demographic, body composition and body fat distribution characteristics in the PA groups
There were no differences in level of education, housing density or asset index between activity groups, however a larger proportion of women from the inactive group were employed (36.3 vs. 20.3%; p = 0.008). Few women smoked (12.2%) and there were no differences in alcohol consumption or hormonal contraceptive use between the activity groups.
Age at baseline, body composition and body fat distribution measurements of the PA groups are presented in Table 2. The active group was significantly younger than the inactive group (p = 0.019) and therefore all subsequent analyses were adjusted for age. Height was not different between the activity groups, however all other measures of whole body fat were significantly lower in the active compared to the inactive group, even after adjusting for age. All absolute measures of regional body fat distribution, including waist and hip circumferences, central fat mass and appendicular fat mass were significantly lower in the active compared to the inactive group, however when expressed as a % of total fat mass, these differences were no longer significant. In addition, SAT was significantly lower in the active compared to the inactive group; however there was no significant difference in VAT or VAT/SAT.
Table 2
Differences in baseline age, body composition and body fat distribution characteristics between the physical activity groups
n
Active
n
Inactive
p values
Age(years)
141
26 ± 7
90
28 ± 8
0.019
Body composition
Age-adjusted p values
Height (m)
141
1.60 ± 0.1
90
1.60 ± 0.1
0.463
Weight (kg)
141
71.7 ± 19.1
90
83.9 ± 20.6
<0.001
BMI (kg/m2)
141
28.0 ± 7.5
90
32.7 ± 8.0
<0.001
Fat-free soft tissue mass (kg)
126
40.9 ± 5.9
74
43.1 ± 6.6
0.025
Fat-free soft tissue mass (%)
126
61.0 ± 7.9
74
56.3 ± 6.9
<0.001
Fat mass (kg)
126
26.0 ± 12.5
74
33.2 ± 12.6
<0.001
Body fat (%)
126
35.8 ± 8.5
74
40.8 ± 7.3
<0.001
Body fat distribution
Waist circumference (cm)
141
86.2 ± 17.0
90
95.3 ± 18.2
0.001
Hip circumference (cm)
141
109.0 ± 15.4
90
117.4 ± 14.8
<0.001
Waist:Hip
141
0.79 ± 0.1
90
0.80 ± 0.1
0.296
CFM (kg)
124
11.5 ± 6.4
74
14.9 ± 6.5
0.001
CFM (% FM)
124
42.0 ± 7.8
74
43.9 ± 4.6
0.091
AFM (kg)
124
14.5 ± 6.3
74
18.3 ± 6.4
<0.001
AFM (% FM)
124
56.4 ± 8.8
74
55.9 ± 4.6
0.855
VAT (cm2)
84
50.0 ± 39.4
53
65.8 ± 36.5
0.088
SAT (cm2)
84
331.6 ± 204.5
53
429.8 ± 188.5
0.044
VAT/SAT
84
0.15 ± 0.1
53
0.16 ± 0.1
0.700
Values are unadjusted mean ± standard deviation or percentage (n). BMI, body mass index; FM, fat mass; CFM, central fat mass; AFM, appendicular fat mass; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue.
Baseline cardio-metabolic outcomes in the PA groups
Baseline cardio-metabolic characteristics of the two PA groups are presented in Table 3. The active group had significantly higher HDL-C concentrations, lower fasting serum insulin concentrations and lower HOMA-IR values compared to their inactive counterparts, before and after adjusting for age. However, these differences were no longer significant after adjusting for age and weight. None of the other cardio-metabolic outcomes were significantly different between activity groups.
Table 3
Differences in baseline cardio-metabolic outcomes between the physical activity groups
n
Active
n
Inactive
Optimal range
p values
Resting blood pressure
Age-adjusted
Age-& weight-adjusted
SBP (mmHg)
141
109.6 ± 16.6
90
111.3 ± 14.0
100 - 140
0.682
0.389
DBP (mmHg)
141
74.0 ± 11.9
90
76.0 ± 9.9
70 - 90
0.797
0.275
Lipid profile
Total cholesterol (mmol/L)
135
3.9 ± 0.8
86
4.1 ± 0.9
3.1 - 5.2
0.711
0.240
LDL-C (mmol/L)
135
2.2 ± 0.7
86
2.3 ± 0.8
1.0 - 3.0
0.307
0.373
HDL-C (mmol/L)
135
1.3 ± 0.4
86
1.2 ± 0.4
1.2 - 1.7
0.041
0.409
Triglycerides (mmol/L)
135
0.7 ± 0.3
86
0.8 ± 0.4
0.5 - 2.0
0.229
0.925
TC/HDL-C
135
3.5 ± 3.8
86
3.7 ± 3.7
-
0.870
0.815
Insulin sensitivity
Fasting plasma glucose (mmol/L)
136
4.5 ± 0.4
85
4.4 ± 0.5
3.1 - 5.5
0.673
0.626
Fasting serum insulin (mU/L)
138
10.1 ± 6.8
89
12.4 ± 8.7
-
0.010
0.353
HOMA-IR
129
2.1 ± 1.4
84
2.6 ± 2.0
-
0.010
0.332
Values are unadjusted mean ± standard deviation. SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low-density lipoprotein cholesterol, HDL-C, high-density lipoprotein cholesterol; TC/HDL-C, total cholesterol to high-density lipoprotein cholesterol ratio; HOMA-IR, homeostasis assessment model of insulin resistance [32]. Normal range values highlighted according to the WHO/International Society for Hypertension (ISH) statement for the management of hypertension [33] and Adult Treatment Panel (ATP) III criteria (2001) [34].
Physical activity: baseline and follow-up
Similar to the original baseline cohort, in the subsample of women (n = 57) who were followed up after 5.5-years, 61.4% (n = 35) of the women were classified as active according to the GPAQ criteria, and 38.6% (n = 22) of the women were classified as inactive. As with the baseline cohort, the majority of PA time was spent in active commuting (transport domain of the GPAQ), particularly walking.
Changes in SES, body composition and body fat distribution from baseline to follow-up (5.5-years) in the PA groups
SES (education, employment and asset index) increased significantly in both groups between baseline and follow-up (education: active 41.6 vs. 48.6%, p = 0.03 and inactive 36.3 vs. 45.4%, p = 0.02; employment: active 11.8 vs. 51.4%, p = 0.01 and inactive 31.8 vs. 40.9%, p = 0.02; asset index: active 6 vs. 9 household appliances, p = 0.03 and inactive 7 vs. 9 household appliances, p = 0.03). Although housing density remained unchanged in the active group, it increased significantly in those who were inactive (1.1 vs. 1.4 persons/room, p = 0.03). There was a significant increase in smoking and alcohol consumption between baseline and follow-up in the active participants (smoking: 11.4 vs. 17.1%, p = 0.02 and alcohol consumption: 34.3 vs. 57.1%, p = 0.02), while smoking did not change and alcohol consumption decreased in their inactive counterparts (36.4 vs. 27.3%, p = 0.03). At follow-up, significantly less of the women in both groups were using hormonal contraceptives (active: 40.0 vs. 25.7%, p = 0.02 and inactive: 50.0 vs. 27.3%, p = 0.01). Overall, changes in SES and lifestyle were not different between the two activity groups.
Body weight and DXA measures of body fatness and fat-free soft tissue mass increased significantly in both activity groups over the 5.5-year follow-up period (Table 4). Notably, the mean % increase in central fat mass was greater than that of peripheral fat mass (appendicular fat mass) in both groups (active: 28.1 vs. 14.8% and inactive: 25.1 vs. 11.4%). Although SAT increased significantly over time in both groups (p = 0.004), VAT and VAT/SAT did not change significantly in either group over the 5.5-year follow-up period. Changes in body composition and body fat distribution were not different between the activity groups.
Table 4
Changes in body composition and body fat distribution from baseline to follow-up (5.5-years) in the PA groups
Active
Inactive
n
Baseline
Follow-up
N
Baseline
Follow-up
Age(years)
35
25 ± 6a
31 ± 6a
22
28 ± 7b
34 ± 7b
Age-adjusted p values
Body composition
Time
Group
Interaction
Height (m)
35
1.59 ± 0.1
1.59 ± 0.1
22
1.60 ± 0.1
1.60 ± 0.1
-
0.328
-
Weight (kg)
35
82.0 ± 19.6a
89.5 ± 19.2a
22
91.0 ± 15.6b
98.3 ± 13.2b
<0.001
0.087
0.730
BMI (kg/m2)
35
32.4 ± 7.5a
35.4 ± 7.6a
22
35.4 ± 5.9b
38.3 ± 6.1b
<0.001
0.181
0.732
FFSTM (kg)
35
44.4 ± 6.5a
45.4 ± 6.5a
22
47.3 ± 5.7b
48.0 ± 4.6b
0.051
0.127
0.825
Fat mass (kg)
35
34.2 ± 14.0a
38.9 ± 13.9a
22
39.5 ± 11.0b
44.7 ± 10.3b
<0.001
0.135
0.490
Body fat (%)
35
40.7 ± 8.6a
43.9 ± 6.4a
22
43.5 ± 6.3b
46.7 ± 5.3b
0.001
0.166
0.823
Body fat distribution
Waist (cm)
35
97.1 ± 17.9a
105.1 ± 17.5a
22
102.4 ± 15.3b
113.6 ± 13.3b
0.001
0.323
0.181
Hip (cm)
35
116.5 ± 16.2
119.4 ± 14.9
22
122.3 ± 10.3
123.7 ± 9.3
0.702
0.185
0.856
Waist: Hip
35
0.83 ± 0.1a
0.87 ± 0.1a
22
0.83 ± 0.1b
0.91 ± 0.1b
0.001
0.455
0.117
CFM (kg)
34
15.9 ± 7.3a
18.7 ± 7.0a
21
18.9 ± 6.6b
22.2 ± 6.3b
<0.001
0.104
0.359
CFM (%FM)
34
37.3 ± 11.1a
41.6 ± 10.4a
21
42.3 ± 10.6b
47.1 ± 9.5b
<0.001
0.083
0.492
AFM (kg)
34
18.2 ± 7.0a
20.1 ± 7.2a
21
20.6 ± 5.0b
22.4 ± 5.2b
0.001
0.704
0.217
AFM (%FM)
34
43.4 ± 9.4a
44.9 ± 10.1a
21
46.7 ± 7.3b
47.8 ± 7.6b
0.014
0.239
0.997
VAT (cm2)
25
58.6 ± 36
75.2 ± 41
14
80.8 ± 51
89.1 ± 48
0.563
0.316
0.452
SAT (cm2)
25
418.7 ± 214a
472.5 ± 187a
14
478.0 ± 142b
511.7 ± 122b
0.004
0.464
0.541
VAT/SAT
25
0.14 ± 0.1
0.16 ± 0.1
14
0.16 ± 0.1
0.18 ± 0.1
0.764
0.785
0.876
Values are unadjusted mean ± standard deviation or percentage (n). Matching superscript letters represent significant differences (p < 0.05) between age-adjusted baseline and follow-up values for each activity group, based on Tukey post-hoc analyses. BMI, body mass index; FM, fat mass; CFM, central fat mass; AFM, appendicular fat mass; VAT, visceral adipose tissue; SAT, subcutaneous adipose tissue.
Changes in cardio-metabolic outcomes from baseline to follow-up (5.5-years) in the PA groups
Changes in the cardio-metabolic characteristics of the two activity groups from baseline to follow-up, adjusting for age, and age and body weight, are presented in Table 5. There was a significant group × time interaction for diastolic blood pressure (DBP), such that DBP decreased in the active group, but did not change in the inactive group, after adjusting for age (p = 0.039), and age and weight (p = 0.035). Total cholesterol, LDL-C and TG serum lipid concentrations did not change over the 5.5-year follow-up period in either activity group, but HDL-C increased significantly in the inactive group after adjusting for age, but not age and weight. Fasting plasma glucose levels did not change over the follow-up period in either of the activity groups. However, fasting serum insulin and HOMA-IR were significantly lower in the active vs. inactive group at baseline and follow-up, after adjusting for age. When adjusting for age and weight, the group difference in fasting serum insulin remained significant; however the difference between the activity groups in HOMA-IR was no longer significant.
Table 5
Changes in cardio-metabolic outcomes from baseline to follow-up (5.5-years) in the physical activity groups
Active
Inactive
p values
n
Baseline
Follow-up
n
Baseline
Follow-up
Age-adjusted
Age- and weight-adjusted
Resting blood pressure
Time
Group
Interaction
Time
Group
Interaction
SBP (mmHg)
35
112 ± 14
110 ± 17
22
113 ± 13
115 ± 19
0.135
0.831
0.479
0.483
0.990
0.446
DBP (mmHg)
35
79 ± 8a
73 ± 13a
22
79 ± 7
81 ± 9
0.081
0.276
0.039
0398
0.288
0.035
Lipid profile
TC (mmol/L)
35
3.8 ± 0.9
4.1 ± 0.9
22
3.6 ± 0.6
3.9 ± 0.9
0.384
0.296
0.870
0.198
0.380
0.733
LDL-C (mmol/L)
35
2.3 ± 0.8
2.5 ± 0.9
22
2.0 ± 0.5
2.4 ± 0.8
0.661
0.210
0.244
0.334
0.309
0.185
HDL-C (mmol/L)
35
1.1 ± 0.3
1.2 ± 0.3
22
1.0 ± 0.4b
1.2 ± 0.3b
0.004
0.918
0.165
0.067
0.965
0.194
TG (mmol/L)
35
0.7 ± 0.3
0.9 ± 0.4
22
0.7 ± 0.3
0.9 ± 0.3
0.307
0.581
0.827
0.279
0.361
0.918
TC/HDL-C
35
3.6 ± 1.4
3.5 ± 1.0
22
3.3 ± 0.7
3.3 ± 0.9
0.441
0.910
0.110
0.919
0.670
0.152
Insulin sensitivity
Fasting plasma glucose (mmol/L)
35
4.5 ± 0.4
5.2 ± 1.7
22
4.6 ± 0.7
5.1 ± 0.8
0.849
0.654
0.821
0.402
0.720
0.402
Fasting serum insulin (mU/L)
35
14.0 ± 7.8a
12.4 ± 6.0b
22
17.8 ± 11.0a
16.4 ± 10.5b
0.125
0.020
0.707
0.655
0.045
0.408
HOMA-IR
34
3.1 ± 1.7a
2.8 ± 1.5b
21
3.7 ± 2.7a
3.7 ± 2.1b
0.145
0.036
0.904
0.950
0.081
0.664
Values are unadjusted mean ± standard deviation. Matching superscript letters represent significant difference (p < 0.05) between age- and weight-adjusted values, based on Tukey post-hoc analyses. SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol, HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; TC/HDL-C, total cholesterol to high-density lipoprotein cholesterol ratio; HOMA-IR, homeostasis assessment model of insulin resistance; Matsuda index, measure of insulin sensitivity [35].
Discussion
The main findings of this study were that 61% of apparently healthy urban dwelling, black SA women in this cohort were classified as sufficiently active according to current GPAQ criteria, which are based on international physical activity recommendations for health [3]. Compared to those who failed to meet GPAQ criteria, the active women had lower body weight and body fat measures, as well as higher serum HDL-C concentrations, and were more insulin sensitive. These differences in cardio-metabolic variables between groups were mediated by body weight. However, being active at baseline did not attenuate the increase in weight that occurred over a 5.5-year follow-up period, but was associated with a significant decrease in DBP.
The findings of the cross-sectional component of this study have shown that women who were active were lighter and had less overall body fat compared to their less active counterparts. Notably, we found that waist circumference of the active group was significantly lower than that of the inactive group, but this was largely due to their lower SAT than VAT. International intervention studies have shown that a significant increase in PAEE is associated with a loss of fat mass from both the VAT and SAT regions [14, 36]. Failure to show a significant difference in VAT between the groups could partly be explained by the smaller sample that had CT measures, but may also relate to the relatively low VAT levels reported in black women from both the USA and SA [15–17]. Goedecke et al. [17] have showed that although both VAT and SAT were associated with reduced insulin sensitivity in black SA women, SAT was more closely related to insulin sensitivity than VAT. Thus, it seems plausible that a significantly lower SAT in black urban women who are sufficiently active may be linked to an improvement in their overall cardio-metabolic profile.
Of particular concern in the longitudinal component of this study was the significant increase in body weight (±7.3 kg) and fat mass (±4.8 kg) over the 5.5-year follow-up period in the free-living women, irrespective of their baseline activity group. Our results show that being active at baseline did not attenuate the increase in weight that occurred over a 5.5-year period in this sample of urban black SA women. Notably, there was a significantly greater increase in central fat mass compared to peripheral fat mass over the follow-up period in both groups. Furthermore, when using the energy balance-related PA guidelines (≥225 min/week) (ASCM’s 2009 Position Stand on PA and Weight Loss) [37] 61.4% of the women in our study were classified as active, however there was still no difference in weight gain between the active and inactive women over the 5.5-year follow-up period. Recent evidence from the SA National Health And Nutrition Examination Survey (SANHANES-1) [38] has highlighted similar age-related trends in weight gain with the largest increases in BMI and WC reported between the ages of 15 and 45 years. When comparing the secular changes in obesity in SA using the data from the SADHS [7] and SANHANES-1 [38], there are significant increases in the prevalence of obesity in women, in particular black women (15–60 years). Evidence from large international prospective cohort studies [39–41] suggest that weight gain is due in part to aging, changes in PA levels, as well as other lifestyle changes, all of which are difficult to characterise [42]. Although results from Luke et al. [43] suggest activity energy expenditure (AEE) plays a limited role in age-related weight gain over a 3-year period, which stems from a more recent meta-analysis comparing objectively measured AEE amongst adult women from HICs and LMICs [44]. To our knowledge, this is the first SA study to examine longitudinal changes in both weight and adiposity level in black urban women. Unfortunately, we were not able to measure the changes in PA over the follow-up period, which may have limited our ability to show an association between activity levels and changes in body composition. Further, GPAQ is reliant on the subjective recall of activity and is not able to accurately assess the intensity of the exercise bout. Future longitudinal studies in this high risk population, whose rate of obesity exceeds 37% (25–34 years) (SANHANES-1) [38], should measure changes in PA in relation to changes in body composition (and cardio-metabolic outcomes) using objective measures of PA that capture not only the intensity of the activity, but also sedentary time.
At baseline, we also showed that women who were active had higher HDL-C levels and were more insulin sensitive (based on fasting insulin and HOMA-IR) compared to their less active counterparts. However, these effects were mediated by differences in body weight. These findings concur with those from other SA studies [10, 12] that showed that active black rural women had significantly higher HDL-C and lower TG concentrations than their inactive counterparts [12]. Furthermore, the most active and overweight (BMI ≥25 kg/m2) women in the Transition and Health During Urbanisation of South Africa (THUSA) study had significantly lower LDL-C concentration and LDL-C:HDL-C ratio, as well as lower fasting serum insulin concentrations, than the inactive overweight women [12]. Despite the majority of women being overweight or obese, as well as very few participating in leisure-time PA, the cross-sectional data provides support for the current MVPA guidelines and the health-derived benefits (reduction in body fat and improved measures of insulin sensitivity) amongst those who met PA criteria.
Despite an increase in body weight in both activity groups, we found that the higher level of insulin sensitivity in the active compared to the inactive group at baseline was still significant at follow up. This is an important and novel finding, and suggests that despite large increases in body fat, the effect of being previously active has lasting effects on insulin sensitivity. As mentioned, we were not able to track changes in PA over the 5.5-year follow-up period, so it is not known whether these women maintained their activity level over time. Nonetheless, this finding is of particular relevance in this population who has a high prevalence of insulin resistance and T2D [7, 38]. In a recent study reporting the prevalence of T2D in a cohort of black urban adults, which is representative of our sample, Peer et al. [45] found that the prevalence of T2D in women was 13.8% (n = 707). However, they found no association between PA levels using the GPAQ and prevalence of T2D, but showed a higher prevalence of physical inactivity in women with T2D compared those who were non-diabetic (11.6 vs. 6.1%, p = 0.035). Future studies are required to confirm our findings using objective measures of PA, as well as direct measures of insulin sensitivity and secretion. Overall, our results highlight the importance of meeting daily PA requirements and its relative influence in reducing cardio-metabolic disease risk.
We also found that despite similar increases in body weight between the activity groups, being active at baseline was associated with a significant decrease in diastolic BP, even after adjusting for age and weight. Potential mechanisms for this finding include sympathetic neural stimulation in response to PA, which results in increased blood flow and vasodilation due to nitric oxide release that provides a stimulus for both acute and chronic changes in vascular function [46]. However, both systolic and DBP remained within a normal range after the 5.5-year period in both groups, and may be due to the relatively young age of the participants. Data from the SANHANES-1 [38] highlights the steady increase in the prevalence of hypertension among SA women across the lifespan (15–60 years). Thus, larger, prospective studies are needed to track possible age-related changes in BP and their association with lifestyle and environmental factors known to affect vascular health [47] in this population.
PA at baseline was not associated with follow-up serum lipid concentrations, which remained relatively low in both groups, despite large increases in body weight over the 5.5-year follow-up period. These findings support evidence from international and other SA studies showing that black women have a more favourable lipid profile when compared to other ethnic groups [48–51] which may be explained, in part, by genetic differences [52–54]. For example, a recent gene-association study amongst black and white SA women (Ellman, personal communication) highlighted a number of ‘protective’ single nucleotide polymorphisms (SNPs) within the cholesteryl ester transfer protein (CETP B1/B2), lipoprotein lipase (LPL S/X) and proprotein convertase subtilisin/kexin type 9 (PCSK9 C/X) genes, which were associated with reduced serum lipid concentrations (LDL-C, TG, TC/HDL-C and TG/HDL-C ratios) in black, but not white women. Other behavioural/lifestyle factors not measured in the study, namely dietary intake could also account for the ethnic differences in serum lipid concentrations.
The strengths of the study include the state-of-the-art measures of body fat and its distribution (DXA and CT). To our knowledge, this is the first study to examine PA as a determinant of change in body composition and cardio-metabolic risk for CVD and T2D over time in black SA women who are at a high risk of CVD. However, numerous limitations should be highlighted and include the use of a convenient sample of women resulting in only 25% of the original sample completing all follow-up tests. In addition, women who refused HIV screening at follow-up were not excluded from the study, which may potentially attenuate the change in body composition measurements. Blood samples for the longitudinal study were not analysed at the same time and using the same assay, which could have increased the variability between measures. Although the intra-assay variability was relatively low, we cannot exclude the possibility that the changes in circulating levels could be due to inter-assay variability. The change in PA level over the 5.5-year follow-up period was not measured. Unfortunately, we were only able to measure PA at baseline and did not measure the subjective changes in PA over the 5.5-year period. Future studies should use objective PA measures (accelerometry) to broaden our knowledge of the relationship between PA at different intensities, and changes in body composition and cardio-metabolic outcomes captured over time [55], particularly in black SA women.
Conclusions
In conclusion, 61% of black apparently healthy women in the cohort were classified as sufficiently active. The majority of PA reported in both activity groups was for travel-purposes (walking), whereas more structured, leisure-time activity was low in this population group. Those who met the PA guidelines had lower body fat, higher serum HDL-C concentrations, and were more insulin sensitive than their inactive counterparts, with the effects of insulin sensitivity still being present at follow-up. However, being active at baseline did not attenuate the increase in body weight that occurred over a 5.5-year follow-up period, but was associated with a significant decrease in DBP. Overall the findings of this study highlight the importance of meeting PA guidelines to reduce cardio-metabolic risk in black SA women. Barriers and determinants of leisure-time PA amongst young black women in SA need to be identified. Furthermore, public health interventions aimed at promoting daily PA to reduce the burden of obesity and its associated morbidities in SA should be designed, implemented and their effectiveness measured.
Declarations
Acknowledgements
The authors would like to acknowledge and thank the research volunteers for their participation in this study, Nandipha Sinyanya for her fieldwork, Hendriena Victor for her technical assistance, Linda Bewerunge for performing the DXA scans and Mark Punyanitya for analysing the CT scans. This study was funded by the Sugar Association of South Africa, the South African Medical Research Council, the International Atomic Energy Agency and the National Research Foundation of South Africa.
LKM acknowledges the MRC/DFID African Research Leader Scheme.
Authors’ Affiliations
(1)
UCT/MRC Research Unit for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town
(2)
Non-Communicable Disease Research Unit, South African Medical Research Council
(3)
MRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Health Sciences, University of Witwatersrand
References
Sesso HD, Paffenbarger RS, Lee IM: Physical activity and coronary heart disease in men: The Harvard Alumni Health Study. Circulation. 2000, 102: 975-980. 10.1161/01.CIR.102.9.975.View ArticlePubMedGoogle Scholar
Li TY, Rana JS, Manson JE, Willett WC, Stampfer MJ, Colditz GA, Rexrode KM, Hu FB: Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006, 113: 499-506. 10.1161/CIRCULATIONAHA.105.574087.View ArticlePubMedPubMed CentralGoogle Scholar
WHO: Global recommendations on physical activity for health. 2010, Geneva, Switzerland: WHOGoogle Scholar
Prince SA, Adamo KB, Hamel ME, Hardt J, Connor GS, Tremblay M: A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review. Int J Behav Nutr Phys Act. 2008, 5: 56-10.1186/1479-5868-5-56.View ArticlePubMedPubMed CentralGoogle Scholar
Bull FC, Maslin TS, Armstrong T: Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009, 6: 790-804.PubMedGoogle Scholar
Guthold R, Louazani SA, Riley LM, Cowan MJ, Bovet P, Damasceno A, Sambo BH, Tesfaye F, Armstrong TP: Physical activity in 22 African countries: results from the World Health Organization STEPwise approach to chronic disease risk factor surveillance. Am J Prev Med. 2011, 41: 52-60. 10.1016/j.amepre.2011.03.008.View ArticlePubMedGoogle Scholar
Department of Health, Medical Research Council, OrcMacro: South Africa Demographic and Health Survey 2003. 2007, Pretoria: Department of HealthGoogle Scholar
Tshabangu EL, Coopoo Y: Physical activity levels and health profiles of adult women living in informal settlements. S A J Res Sport, Phys Educ Recreation. 2001, 23: 27-36.Google Scholar
Cook I: Physical activity in rural South Africa–are current surveillance instruments yielding valid results?. S Afr Med J. 2007, 97: 1072-1073.PubMedGoogle Scholar
Cook I, Alberts M, Lambert EV: Development of a four-item physical activity index from information about subsistence living in rural African women: a descriptive, cross-sectional investigation. Int J Behav Nutr Phys Act. 2009, 6: 75-10.1186/1479-5868-6-75.View ArticlePubMedPubMed CentralGoogle Scholar
Kruger HS, Venter CS, Vorster HH, Margetts BM: Physical inactivity is the major determinant of obesity in black women in the North West Province, South Africa: the THUSA study. Transition and Health During Urbanisation of South Africa. Nutrition. 2002, 18: 422-427. 10.1016/S0899-9007(01)00751-1.View ArticlePubMedGoogle Scholar
Kruger HS, Venter CS, Vorster HH: Physical inactivity as a risk factor for cardiovascular disease in communities undergoing rural to urban transition: the THUSA study. Cardiovasc J S Afr. 2003, 14: 16-23.PubMedGoogle Scholar
Thomas EL, Brynes AE, McCarthy J, Goldstone AP, Hajnal JV, Saeed N, Frost G, Bell JD: Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids. 2000, 35: 769-776. 10.1007/s11745-000-0584-0.View ArticlePubMedGoogle Scholar
Ross R, Janssen I, Dawson J, Kungl AM, Kuk JL, Wong SL, Nguyen-Duy TB, Lee S, Kilpatrick K, Hudson R: Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res. 2004, 12: 789-798. 10.1038/oby.2004.95.View ArticlePubMedGoogle Scholar
Osei K, Cottrell DA: Minimal model analyses of insulin sensitivity and glucose-dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes. Eur J Clin Invest. 1994, 24: 843-850. 10.1111/j.1365-2362.1994.tb02029.x.View ArticlePubMedGoogle Scholar
van der Merwe MT, Crowther NJ, Schlaphoff GP, Gray IP, Joffe BI, Lonnroth PN: Evidence for insulin resistance in black women from South Africa. Int J Obes Relat Metab Disord. 2000, 24: 1340-1346. 10.1038/sj.ijo.0801416.View ArticlePubMedGoogle Scholar
Goedecke JH, Levitt NS, Lambert EV, Utzschneider KM, Faulenbach MV, Dave JA, West S, Victor H, Evans J, Olsson T, Walker BR, Seckl JR, Kahn SE: Differential effects of abdominal adipose tissue distribution on insulin sensitivity in black and white South African women. Obesity (Silver Spring). 2009, 17: 1502-1512.View ArticleGoogle Scholar
Assah FK, Ekelund U, Brage S, Mbanya JC, Wareham NJ: Free-living physical activity energy expenditure is strongly related to glucose intolerance in Cameroonian adults independently of obesity. Diabetes Care. 2009, 32: 367-369.View ArticlePubMedPubMed CentralGoogle Scholar
Hu FB, Sigal RJ, Rich-Edwards JW, Colditz GA, Solomon CG, Willett WC, Speizer FE, Manson JE: Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA. 1999, 282: 1433-1439. 10.1001/jama.282.15.1433.View ArticlePubMedGoogle Scholar
Mora S, Lee IM, Buring JE, Ridker PM: Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA. 2006, 295: 1412-1419. 10.1001/jama.295.12.1412.View ArticlePubMedGoogle Scholar
Sobngwi E, Mbanya JC, Unwin NC, Kengne AP, Fezeu L, Minkoulou EM, Aspray TJ, Alberti KG: Physical activity and its relationship with obesity, hypertension and diabetes in urban and rural Cameroon. Int J Obes Relat Metab Disord. 2002, 26: 1009-1016.View ArticlePubMedGoogle Scholar
Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH: Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity (Silver Spring). 2008, 16: 1602-1609. 10.1038/oby.2008.233.View ArticleGoogle Scholar
Joffe YT, van der Merwe L, Carstens M, Collins M, Jennings C, Levitt NS, Lambert EV, Goedecke JH: Tumor necrosis factor-alpha gene -308 G/A polymorphism modulates the relationship between dietary fat intake, serum lipids, and obesity risk in black South African women. J Nutr. 2010, 140: 901-907. 10.3945/jn.109.109355.View ArticlePubMedGoogle Scholar
WHO: The STEPS Global Physical Activity Questionnaire Analysis Guide. 2010, Geneva, Switzerland: WHOGoogle Scholar
Goedecke JH, Micklesfield LK, Levitt NS, Lambert EV, West S, Maartens G, Dave JA: Effect of different antiretroviral drug regimens on body fat distribution of HIV-infected South African women. AIDS Res Hum Retroviruses. 2013, 29: 557-563. 10.1089/aid.2012.0252.View ArticlePubMedGoogle Scholar
Micklesfield LK, Reid S, Bewerunge L, Rush EC, Goedecke JH: A proposed method to measure body composition in obese individuals using dual-energy X-ray absorptiometry. Int J Body Composition Res. 2007, 5: 147-151.Google Scholar
Smith SR, Lovejoy JC, Greenway F, Ryan D, De Jonge L, De La Bretonne J, Volafova J, Bray GA: Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001, 50: 425-435. 10.1053/meta.2001.21693.View ArticlePubMedGoogle Scholar
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMedGoogle Scholar
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.View ArticlePubMedGoogle Scholar
Armstrong T, Bull F: Development of the World Health Organization Global Physical Activity Questionnaire (GPAQ). J Pub Health. 2006, 14: 66-70. 10.1007/s10389-006-0024-x.View ArticleGoogle Scholar
Trinh OT, Nguyen ND, van der Ploeg HP, Dibley MJ, Bauman A: Test-retest repeatability and relative validity of the Global Physical Activity Questionnaire in a developing country context. J Phys Act Health. 2009, 6 (Suppl 1): S46-S53.PubMedGoogle Scholar
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.View ArticlePubMedGoogle Scholar
Whitworth JA: World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003, 2003 (21): 1983-1992.Google Scholar
Expert Panel on Detecion, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.View ArticleGoogle Scholar
Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999, 22: 1462-1470. 10.2337/diacare.22.9.1462.View ArticlePubMedGoogle Scholar
Despres JP, Pouliot MC, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, Theriault G, Bouchard C: Loss of abdominal fat and metabolic response to exercise training in obese women. Am J Physiol. 1991, 261: E159-E167.PubMedGoogle Scholar
Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK: American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009, 41: 459-471.View ArticlePubMedGoogle Scholar
Shisana O, Labadarios D, Rehle T, Simbayi L, Zuma K, Dhansay A, Reddy A, Parker P, Hoosain E, Naidoo P, Hongoro C, Mchiza Z, Steyn NP, Dwane N, Makoae M, Maluleke T, Ramlagan S, Zungu N, Evans MG, Jacobs L, Faber M, SANHANES-1 Team: Results: Health status of adults: national estimates of NCDs and major risk factors. South African National Health and Nutrition Examination Survey (SANHANES-1). 2013, Cape Town: HSRC Press, 70-91.Google Scholar
Van Lenthe FJ, Droomers M, Schrijvers CT, Mackenbach JP: Socio-demographic variables and 6 year change in body mass index: longitudinal results from the GLOBE study. Int J Obes Relat Metab Disord. 2000, 24: 1077-1084. 10.1038/sj.ijo.0801236.View ArticlePubMedGoogle Scholar
Ball K, Crawford D, Ireland P, Hodge A: Patterns and demographic predictors of 5-year weight change in a multi-ethnic cohort of men and women in Australia. Public Health Nutr. 2003, 6: 269-281.View ArticlePubMedGoogle Scholar
Brown WJ, Williams L, Ford JH, Ball K, Dobson AJ: Identifying the energy gap: magnitude and determinants of 5-year weight gain in midage women. Obes Res. 2005, 13: 1431-1441. 10.1038/oby.2005.173.View ArticlePubMedGoogle Scholar
Crawford D, Jeffery RW, French SA: Can anyone successfully control their weight? Findings of a three year community-based study of men and women. Int J Obes Relat Metab Disord. 2000, 24: 1107-1110. 10.1038/sj.ijo.0801374.View ArticlePubMedGoogle Scholar
Luke A, Dugas LR, Ebersole K, Durazo-Arvizu RA, Cao G, Schoeller DA, Adeyemo A, Brieger WR, Cooper RS: Energy expenditure does not predict weight change in either Nigerian or African American women. Am J Clin Nutr. 2009, 89: 169-176.View ArticlePubMedGoogle Scholar
Dugas LR, Harders R, Merrill S, Ebersole K, Shoham DA, Rush EC, Assah FK, Forrester T, Durazo-Arvizu RA, Luke A: Energy expenditure in adults living in developing compared with industrialized countries: a meta-analysis of doubly labeled water studies. Am J Clin Nutr. 2011, 93: 427-441. 10.3945/ajcn.110.007278.View ArticlePubMedGoogle Scholar
Peer N, Steyn K, Lombard C, Lambert EV, Vythilingum B, Levitt NS: Rising diabetes prevalence among urban-dwelling black South Africans. PLoS One. 2012, 7: e43336-10.1371/journal.pone.0043336.View ArticlePubMedPubMed CentralGoogle Scholar
Maiorana A, O'Driscoll G, Taylor R, Green D: Exercise and the nitric oxide vasodilator system. Sports Med. 2003, 33: 1013-1035. 10.2165/00007256-200333140-00001.View ArticlePubMedGoogle Scholar
Cheng S, Xanthakis V, Sullivan LM, Vasan RS: Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension. 2012, 60: 1393-1399. 10.1161/HYPERTENSIONAHA.112.201780.View ArticlePubMedPubMed CentralGoogle Scholar
Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC: Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism. 2005, 54: 902-909. 10.1016/j.metabol.2005.03.001.View ArticlePubMedGoogle Scholar
Despres JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol. 2000, 20: 1932-1938. 10.1161/01.ATV.20.8.1932.View ArticlePubMedGoogle Scholar
Goedecke JH, Utzschneider K, Faulenbach MV, Rizzo M, Berneis K, Spinas GA, Dave JA, Levitt NS, Lambert EV, Olsson T, Kahn SE: Ethnic differences in serum lipoproteins and their determinants in South African women. Metabolism. 2000, 59: 1341-1350.View ArticleGoogle Scholar
Sliwa K, Lyons JG, Carrington MJ, Lecour S, Marais AD, Raal FJ, Stewart S: Different lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease. Cardiovasc J Afr. 2012, 23: 389-395. 10.5830/CVJA-2012-036.View ArticlePubMedPubMed CentralGoogle Scholar
Cuchel M, Wolfe ML, DeLemos AS, Rader DJ: The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians. Atherosclerosis. 2002, 163: 169-174. 10.1016/S0021-9150(01)00769-9.View ArticlePubMedGoogle Scholar
Nettleton JA, Steffen LM, Ballantyne CM, Boerwinkle E, Folsom AR: Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. Atherosclerosis. 2007, 194: e131-e140. 10.1016/j.atherosclerosis.2006.11.025.View ArticlePubMedGoogle Scholar
Hooper AJ, Marais AD, Tanyanyiwa DM, Burnett JR: The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population. Atherosclerosis. 2007, 193: 445-448. 10.1016/j.atherosclerosis.2006.08.039.View ArticlePubMedGoogle Scholar
Swartz AM, Strath SJ, Bassett DR, O'Brien WL, King GA, Ainsworth BE: Estimation of energy expenditure using CSA accelerometers at hip and wrist sites. Med Sci Sports Exerc. 2000, 32: S450-S456. 10.1097/00005768-200009001-00003.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
